163 related articles for article (PubMed ID: 26289793)
1. Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis.
Saito K; Uebanso T; Maekawa K; Ishikawa M; Taguchi R; Nammo T; Nishimaki-Mogami T; Udagawa H; Fujii M; Shibazaki Y; Yoneyama H; Yasuda K; Saito Y
Sci Rep; 2015 Aug; 5():12466. PubMed ID: 26289793
[TBL] [Abstract][Full Text] [Related]
2. Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human.
Ochoa-Rios S; O'Connor IP; Kent LN; Clouse JM; Hadjiyannis Y; Koivisto C; Pecot T; Angel PM; Drake RR; Leone G; Mehta AS; Rockey DC
Mol Cell Proteomics; 2022 May; 21(5):100225. PubMed ID: 35331917
[TBL] [Abstract][Full Text] [Related]
3. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
Hall Z; Bond NJ; Ashmore T; Sanders F; Ament Z; Wang X; Murray AJ; Bellafante E; Virtue S; Vidal-Puig A; Allison M; Davies SE; Koulman A; Vacca M; Griffin JL
Hepatology; 2017 Apr; 65(4):1165-1180. PubMed ID: 27863448
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice.
Cho YE; Kim Y; Kim SJ; Lee H; Hwang S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895168
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
Schwabe RF; Tabas I; Pajvani UB
Gastroenterology; 2020 May; 158(7):1913-1928. PubMed ID: 32044315
[TBL] [Abstract][Full Text] [Related]
6. Lipidomic signatures discriminate subtle hepatic changes in the progression of porcine nonalcoholic steatohepatitis.
Herrera-Marcos LV; Martínez-Beamonte R; Arnal C; Barranquero C; Puente-Lanzarote JJ; Lou-Bonafonte JM; Gonzalo-Romeo G; Mocciaro G; Jenkins B; Surra JC; Rodríguez-Yoldi MJ; Alastrué-Vera V; Letosa J; García-Gil A; Güemes A; Koulman A; Osada J
Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G411-G425. PubMed ID: 38375587
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomics reveal a molecular signature in the progression of nonalcoholic steatohepatitis and identifies PAI‑1 and MMP‑9 as biomarkers in
Zhao Y; Yakufu M; Ma C; Wang B; Yang J; Hu J
Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 38038126
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH).
Li X; Bhattacharya D; Yuan Y; Wei C; Zhong F; Ding F; D'Agati VD; Lee K; Friedman SL; He JC
Kidney Int; 2024 Mar; 105(3):540-561. PubMed ID: 38159678
[TBL] [Abstract][Full Text] [Related]
9. Limited role for hyperammonemia in the progression of diet-induced nonalcoholic steatohepatitis.
Wang ZX; Wang MY; Yang RX; Ren TY; Zhao ZH; Xin FZ; Fan JG
J Dig Dis; 2023; 24(6-7):408-418. PubMed ID: 37529891
[TBL] [Abstract][Full Text] [Related]
10. A Novel Mouse Model of Nonalcoholic Steatohepatitis Suggests that Liver Fibrosis Initiates around Lipid-Laden Macrophages.
Ichimura-Shimizu M; Tsuchiyama Y; Morimoto Y; Matsumoto M; Kobayashi T; Sumida S; Kakimoto T; Oya T; Ogawa H; Yamashita M; Matsuda S; Omagari K; Taira S; Tsuneyama K
Am J Pathol; 2022 Jan; 192(1):31-42. PubMed ID: 34710382
[TBL] [Abstract][Full Text] [Related]
11. Egr2 drives the differentiation of Ly6C
Iwata A; Maruyama J; Natsuki S; Nishiyama A; Tamura T; Tanaka M; Shichino S; Seki T; Komai T; Okamura T; Fujio K; Tanaka M; Asano K
Commun Biol; 2024 Jun; 7(1):681. PubMed ID: 38831027
[TBL] [Abstract][Full Text] [Related]
12. Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis.
Soeda K; Sasako T; Enooku K; Kubota N; Kobayashi N; Ikushima YM; Awazawa M; Bouchi R; Toda G; Yamada T; Nakatsuka T; Tateishi R; Kakiuchi M; Yamamoto S; Tatsuno K; Atarashi K; Suda W; Honda K; Aburatani H; Yamauchi T; Fujishiro M; Noda T; Koike K; Kadowaki T; Ueki K
Nat Commun; 2023 Oct; 14(1):6584. PubMed ID: 37852976
[TBL] [Abstract][Full Text] [Related]
13. BET Inhibition Improves NASH and Liver Fibrosis.
Middleton SA; Rajpal N; Cutler L; Mander P; Rioja I; Prinjha RK; Rajpal D; Agarwal P; Kumar V
Sci Rep; 2018 Nov; 8(1):17257. PubMed ID: 30467325
[TBL] [Abstract][Full Text] [Related]
14. 6-Amino[1,2,5]oxadiazolo[3,4-
Salamoun JM; Garcia CJ; Hargett SR; Murray JH; Chen SY; Beretta M; Alexopoulos SJ; Shah DP; Olzomer EM; Tucker SP; Hoehn KL; Santos WL
J Med Chem; 2020 Jun; 63(11):6203-6224. PubMed ID: 32392051
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Stress Linked Organ Lipid Hydroperoxidation and Dysregulation in Mouse Model of Nonalcoholic Steatohepatitis: Revealed by Lipidomic Profiling of Liver and Kidney.
Wu Y; Chen Z; Fuda H; Tsukui T; Wu X; Shen N; Saito N; Chiba H; Hui SP
Antioxidants (Basel); 2021 Oct; 10(10):. PubMed ID: 34679736
[TBL] [Abstract][Full Text] [Related]
16. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis.
Reisman SA; Ferguson DA; Lee CI; Proksch JW
J Biochem Mol Toxicol; 2020 Sep; 34(9):e22526. PubMed ID: 32410268
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological analysis of the progression of hepatic lesions in STAM mice.
Saito T; Muramatsu M; Ishii Y; Saigo Y; Konuma T; Toriniwa Y; Miyajima K; Ohta T
Physiol Res; 2017 Nov; 66(5):791-799. PubMed ID: 28730823
[TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.
Nakagawa H
World J Hepatol; 2015 Aug; 7(17):2110-8. PubMed ID: 26301053
[TBL] [Abstract][Full Text] [Related]
20. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.
Asgharpour A; Cazanave SC; Pacana T; Seneshaw M; Vincent R; Banini BA; Kumar DP; Daita K; Min HK; Mirshahi F; Bedossa P; Sun X; Hoshida Y; Koduru SV; Contaifer D; Warncke UO; Wijesinghe DS; Sanyal AJ
J Hepatol; 2016 Sep; 65(3):579-88. PubMed ID: 27261415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
